NCT00747032View on ClinicalTrials.gov

To Demonstrate the Superior Efficacy of NYC 0462 Ointment Over That of the Placebo in the Treatment of Plaque Psoriasis

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2010

Primary Completion Date

February 28, 2011

Study Completion Date

April 30, 2011

Conditions
Plaque Psoriasis
Interventions
DRUG

NYC 0462 Ointment

To assess the efficacy of NYC 0462 Ointment versus Placebo in the treatment of Plaque Psoriasis

DRUG

Placebo

To assess the efficacy of NYC 0462 Ointment versus Placebo in the treatment of Plaque Psoriasis

Sponsors
All Listed Sponsors
lead

Fougera Pharmaceuticals Inc.

INDUSTRY

NCT00747032 - To Demonstrate the Superior Efficacy of NYC 0462 Ointment Over That of the Placebo in the Treatment of Plaque Psoriasis | Biotech Hunter | Biotech Hunter